Avinger (NSDQ:AVGR) said today it signed an agreement with group purchasing organization HealthTrust for Avinger’s portfolio of peripheral artery disease products. Get the full story at our sister site, Medical Design & Outsourcing.
Avinger
Avinger prices $30m follow-on offering
Avinger (NSDQ:AVGR) today priced a follow-on offering worth $30 million, saying it plans to dip into the cash if it needs to cover penalties for missed revenue covenants this year. Redwood City, Calif.-based Avinger said it plans to float nearly 8.6 million shares at $3.50 apiece, plus a possible 1.3-million-share underwriters over-allotment that could bring in another […]
Avinger lowers outlook on Q2 sales prelims
Avinger (NSDQ:AVGR) shares are off nearly 39% today after the company released lower-than-expected preliminary 2nd-quarter sales numbers and lowered its outlook for the rest of the year. Redwood City, Calif.-based Avinger, which makes the Pantheris image-guided atherectomy device for treating peripheral artery disease, said it expects to post sales of $4.7 million for the 3 months ended June […]
Insurer launches trial of Avinger’s Pantheris atherectomy device
Avinger (NSDQ:AVGR) said yesterday that it is collaborating with health insurers Highmark Health and Allegheny Health Network to launch a trial of its Pantheris image-guided atherectomy device designed for treating peripheral artery disease. The Pantheris device is designed to use optical coherence tomography to allow physicians to visualize the vessel and obstruction during atherectomy procedures to […]
Avinger, fresh off Pantheris launch, inks $50m stock deal
Avinger (NSDQ:AVGR), which earlier this month launched a new version of its Pantheris peripheral atherectomy device, registered for the sale of up to $50 million worth of its stock. Redwood City, Calif.-based Avinger said the deal with Cowen & Co. doesn’t oblige it to sell any shares. Last week the company said it would immediately launch an […]
VIVA 2015 Roundup: Medtronic touts Valiant stent graft, PAD stent-treatment data
Medtronic (NYSE:MDT) this week presented data from 2 studies of its stent systems and announced a new study of its In.Pact Admiral drug-coated balloon. The announcements were made at the VIVA physicians annual conference in Las Vegas, Nev. The Fridley, Minn.-based medical giant presented data from a 2-year clinical trial of its Valiant Captivia thoracic stent graft […]
Avinger pulls in $55m term loan
Avinger said it won a $55 million term loan and securities purchase agreement with CRG. The Redwood City, Calif.-based company took out $30 million initially with interest paid over 4 years. CRG purchased $5 million in shares from Avinger along with the loan. “We are pleased to support Avinger in achieving its growth plans and […]
Ex-FDA chief Hamburg moves to Institute of Medicine | Personnel Moves
Dr. Margaret Hamburg, who resigned as FDA commissioner in February, was named foreign secretary of the U.S. Institute of Medicine this week.
Hamburg spent 6 years leading the federal safety watchdog, overseeing a massive revamp of its medical device, drug, food and tobacco regulation.
IPO Thursday: Avinger, Entellus upsize, Presbia prices under range
Ex-Insulet CFO Roberts lands at Avedro | Personnel Moves
Avinger sets terms for $60m IPO
Avinger today set the terms for its pending initial public offering, striking a midpoint that would see it fetch $59.9 million in public trading.
The Redwood City, Calif.-based company makes a family of vascular catheters aimed at the peripheral vascular market.